Intellectual Property counsel, Abigail Langsam will be moderating a panel for The New York Intellectual Property Law Association on hot topics and issues in the biosimilars space. The panel will focus on recent case law and provide commentary from both the brand and biosimilar perspective on future application of the BPCIA, regulatory issues and FDA strategy, as well as the need to be actively engaged with the FDA no matter which side you are on.
The event will take place on February 29, 2016 and is hosted by the Women in IP Law Committee.
You will earn 1.0 NY/NJ CLE professional credit.
This event is open for both newly admitted and experienced attorneys.
Terry Rea, partner, Crowell & Moring; former acting and deputy director of the United States Patent and Trademark Office (USPTO)
Robert M. Isackson, partner, Orrick, Herrington & Sutcliffe LLP
Chad Landmon, partner, Axinn, Veltrop & Harkrider LLP
David Leichtman, partner, Robins Kaplan LLP
6:00 p.m.– 6:30 p.m. Registration & Pre-reception
6:30 p.m.– 7:30 p.m. Presentation
7:30 p.m.– 8:00 p.m. Post-reception
Where & When
February 29, 2016Axinn, 114 West 47th Street, New York